Hospital.Help

Gold Coast – The opioid antagonist naltrexone, used for alcohol use disorders and opioid addiction, could also help patients with Long COVID. This is suggested by a study from Australia published in Frontiers in Immunology (2024; DOI: 10.3389/fimmu.2024.1264702). First author Etianne Martini Sasso from the National Center for Neuroimmunology and Emerging Diseases (NCNED) at Griffith University in Gold Coast and her colleagues show…